| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |